Pacira BioSciences stockholders approve stock plan adding 2,500,000 shares
At its June 10, 2025 annual meeting, Pacira BioSciences stockholders approved an amended and restated 2011 Stock Incentive Plan that increases the shares authorized for grant by 2,500,000, and elected three Class II directors. Stockholders rejected the advisory say-on-pay vote, with 22,595,202 votes against and 14,752,829 for, and the board will hold say-on-pay votes every year.
- Stock incentive plan approved: 22,043,902 for, 15,317,588 against, 20,318 abstain, 8,909,022 broker non-votes; 2,500,000 newly reserved shares
- Advisory say-on-pay vote failed: 14,752,829 for, 22,595,202 against, 33,777 abstain; board will hold these votes annually
- Marcelo Bigal, Frank D. Lee and Alethia Young elected as Class II directors to serve until the 2028 annual meeting; KPMG LLP ratified for fiscal 2025 with 40,022,569 for